已发表论文

牛磺酸衍生碳点在结直肠癌中的诊疗应用:诱导铁死亡及多面抗肿瘤机制

 

Authors Zhang R , Lan S , Jia M , Liu F , Wang M, Jin Q, Su L, Liu G 

Received 22 January 2025

Accepted for publication 20 May 2025

Published 16 June 2025 Volume 2025:20 Pages 7613—7635

DOI https://doi.org/10.2147/IJN.S516926

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. RDK Misra

Rongrong Zhang,1,* Shuting Lan,1,* Mengxuan Jia,1,* Fangyuan Liu,1 Mengqi Wang,2 Qin Jin,3 Liya Su,1 Gang Liu1 

1Clinical Medicine Research Center, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, People’s Republic of China; 2College of Life Science and Oceanography, Weifang University, Weifang, Shandong, People’s Republic of China; 3Department of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Gang Liu, Email 20190043@immu.edu.cn

Introduction: The theranostic potential of taurine-derived carbon dots (Tau/CDs) in colorectal cancer (CRC) remains largely unexplored, despite their promising physicochemical and biological properties.
Methods: In this study, Tau/CDs were synthesized via a microwave-assisted irradiation method, employing citric acid as the carbon source, urea as the nitrogen source, and taurine (Tau) as the dopant. Comprehensive physicochemical characterization and biocompatibility assessments were performed both in vitro and in vivo. The anti-cancer efficacy of Tau/CDs against CRC was systematically evaluated through a series of functional assays, including cell viability, proliferation, migration, invasion, adhesion, clonogenicity, cell cycle progression, apoptosis, epithelial-mesenchymal transition (EMT), and transcriptomic profiling. The therapeutic efficacy was further validated in vivo using CRC xenograft murine models.
Results: Tau/CDs exhibited excellent biocompatibility and significantly impaired key malignant properties of CRC cells, including viability, proliferation, migration, invasion, clonogenicity, and EMT. Treatment with Tau/CDs induced cell cycle arrest and apoptosis in vitro, while in vivo administration robustly suppressed tumor growth in xenograft models. Mechanistically, transcriptomic analysis combined with ferroptosis profiling identified Heme Oxygenase 1 (HO-1)-mediated ferroptosis as a critical pathway underlying the anti-tumor activity of Tau/CDs.
Conclusion: Microwave-assisted synthesis of Tau/CDs from citric acid, urea, and Tau yielded biocompatible nanoparticles with potent anti-cancer properties. Tau/CDs were shown to inhibit CRC progression by regulating multiple malignant phenotypes, with HO-1-mediated ferroptosis emerging as a critical mechanistic axis. These findings highlight Tau/CDs as a promising candidate for future clinical translation in CRC nanomedicine.

Keywords: taurine, carbon dots, colorectal cancer, ferroptosis, HO-1